AURKA and inflammatory breast carcinoma: We then explored the expression levels of AURKA in the dataset from Van Laere et al. 2013 [3], confirming the increase of AURKA mRNA expression within patients with IBC as compared to patients with non-IBC, in line with previous reports from patients [19] and cell lines data [20] (Fig. 2 B,C and Supplementary Table 7).